TrialAnnals of the rheumatic diseases2024

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).

Yves-Marie Pers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.